Search

for
Search:

GlossaryD-dimer

small protein fragment indicating blood clot breakdown

D-dimer is a small protein fragment that is produced when a blood clot dissolves in the body. The D-dimer test is commonly used to help diagnose or rule out conditions related to abnormal clotting, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). Elevated levels of D-dimer in the blood can indicate the presence of an abnormal clotting process, but further testing is often required to pinpoint the exact cause.

Related Terms

Learn

5 / 5 results

learn D-Pantothenyl Alcohol

learn Vitamin D

vitamin you should probably be taking for general health might also help your hair a little

Research

5 / 1000+ results

research Investigating Biochemical Biomarkers in Telogen Effluvium Post-COVID-19 Patients: A Retrospective Cohort Study

September 2024 in “Journal of Bioscience and Applied Research/Journal of Bioscience and Applied Research ”

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis

114 citations, January 2021 in “medRxiv (Cold Spring Harbor Laboratory)”

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

research Thrombin Activatable Fibrinolysis Inhibitor and Other Hemostatic Parameters in Patients with Polycystic Ovary Syndrome

29 citations, January 2009 in “Gynecological Endocrinology”

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

View more "d-dimer" in research →

Community Join

5 / 1000+ results

community HLT Megathread on HMI-115 (key takeaways in comments)

in Research/Science 39 upvotes 1 year ago

HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

View more "d-dimer" in community →